Target intelligence / Profile preview

DNA–Calcium–DNA bridges (eDNA–Ca²⁺–DNA bridges)

Target
eDNA–Ca²⁺–DNA bridges
Molecular classification
Extracellular matrix component, Structural complex, Biofilm matrix component, Nucleic acid-metal ion complex
01

Overview

DNA–Calcium–DNA bridges are essential structural motifs within the extracellular polymeric substance (EPS) that constitutes the matrix of bacterial biofilms (Whitchurch et al., 2002). These bridges are formed through the electrostatic interaction between negatively charged extracellular DNA (eDNA) and divalent calcium ions (Ca²⁺), which act as cross-linking agents to provide mechanical strength and viscoelasticity to the biofilm (Das et al., 2014). This structural framework serves as a physical barrier that protects pathogenic bacteria from the host's immune system and significantly reduces the penetration of antibiotics, contributing to the persistence of chronic infections (Gloag et al., 2013). Clinically, these bridges are highly relevant in conditions such as Pseudomonas aeruginosa infections in cystic fibrosis and medical device-related biofilms (Mulcahy et al., 2008). Therapeutic strategies target these bridges by using DNA-degrading enzymes like Dornase alfa to cleave the DNA backbone or calcium-chelating agents like EDTA to sequester the ions, thereby liquefying the matrix and enhancing the efficacy of co-administered antimicrobial agents (Jones et al., 2013).

Other names
Extracellular DNA-calcium complexeseDNA-cation bridgeseDNA-Ca2+ cross-linksCalcium-mediated eDNA networkseDNA-Ca2+-eDNA complexes
02

Mechanism of action

Chelation of divalent calcium ions to destabilize electrostatic cross-links and enzymatic hydrolysis of extracellular DNA to degrade the structural scaffold of the biofilm matrix.

03

Biological functions

Biofilm structural integrityBacterial adhesionAntimicrobial resistanceViscoelasticity regulationExtracellular polymeric substance (EPS) stabilizationHorizontal gene transfer scaffold
04

Disease associations

InfectionCystic fibrosisChronic wound infectionDental cariesCatheter-associated urinary tract infection (CAUTI)Endocarditis
05

Safety considerations

Systemic hypocalcemiaElectrolyte imbalanceMucosal irritationPotential release of sequestered bacterial toxins during matrix dissolutionTransient increase in bacterial dispersal
06

Interacting drugs

Dornase alfa

4 more in the full profile.

07

Biomarkers

Extracellular DNA (eDNA) concentrationBiofilm calcium levelsBiofilm viscositySputum eDNA levels

Beyond the preview

Go deeper on DNA–Calcium–DNA bridges (eDNA–Ca²⁺–DNA bridges).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA–Calcium–DNA bridges (eDNA–Ca²⁺–DNA bridges).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call